Patients' Reasons for Returning to ER Differ From Predicted

This article originally appeared here.
Share this content:
Patients' Reasons for Returning to ER Differ From Predicted
Patients' Reasons for Returning to ER Differ From Predicted

FRIDAY, Oct. 23, 2015 (HealthDay News) -- Patients' reasons for returning to the emergency department after discharge from an internal medicine unit include being discharged too soon and feeling weak, and these reasons differ from those predicted by the liaison nurse clinician's evaluation, according to a study published online Oct. 14 in the Journal of Clinical Nursing.

Molywan Vat, R.N., from McGill University in Montreal, and colleagues conducted a qualitative, descriptive study to examine the reasons for returning to the emergency department soon after discharge from an internal medicine unit. They compared eight patients' reasons with data from the liaison nurse clinician's risk assessment tools used for discharge planning.

The researchers found that for most patients, being discharged too soon, feeling weak at discharge, having limited help at home with managing chronic illness, and inadequate discharge instructions accounted for the return to the emergency department. There was a difference between the participants' reasons for returning and those predicted by the liaison nurse clinician's evaluation.

"The findings suggest that health care professionals should adopt a standardized process to evaluate several components of the patients' health status before their discharge, such as physical autonomy, remission of symptoms and the patients' ability to manage their care," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths